Prospective, controlled, randomized non-blind comparison of intravenous/oral ciprofloxacin with intravenous ceftazidime in the treatment of skin or soft-tissue infections.
Dominguez
J
J
Department of Dermatology, Hopital General Dr. Manuel Gea Gonzalez, Mexico City, Mexico.
Palma
F
F
Vega
M E
ME
Magaña
J L
JL
Ortiz
G
G
Teresa-Hojyo
M
M
Dominguez
L
L
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D002442:Ceftazidime / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002939:Ciprofloxacin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007262:Infusions, Intravenous; D008875:Middle Aged; D011446:Prospective Studies; D011897:Random Allocation; D012874:Skin Diseases, Infectious / Q000188:drug therapy*
D002939:Ciprofloxacin; D002442:Ceftazidime